Your browser doesn't support javascript.
loading
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese, Silvio; Vermeire, Severine; D'Haens, Geert; Panés, Julian; Dignass, Axel; Magro, Fernando; Nazar, Maciej; Le Bars, Manuela; Lahaye, Marjolein; Ni, Lioudmila; Bravata, Ivana; Lavie, Frederic; Daperno, Marco; Lukás, Milan; Armuzzi, Alessandro; Löwenberg, Mark; Gaya, Daniel R; Peyrin-Biroulet, Laurent.
Affiliation
  • Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy. Electronic address: sdanese@hotmail.com.
  • Vermeire S; University Hospitals Leuven, Leuven, Belgium.
  • D'Haens G; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Panés J; Department of Gastroenterology, Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
  • Dignass A; Department of Medicine I, Agaplesion Markus Hospital, Frankfurt/Main, Germany.
  • Magro F; Department of Pharmacology & Therapeutics, Institute for Molecular and Cell Biology, Faculty of Medicine University of Porto, and Department of Gastroenterology, Hospital de São João, Porto, Portugal.
  • Nazar M; Janssen-Cilag, Polska Sp. z o.o, Warsaw, Poland.
  • Le Bars M; Janssen-Cilag, Medical Affairs, Issy-les-Moulineaux, France.
  • Lahaye M; Janssen-Cilag, B.V., Medical Affairs, Breda, Netherlands.
  • Ni L; Janssen-Cilag, Medical Affairs, Moscow, Russia.
  • Bravata I; Janssen-Cilag, Milan, Italy.
  • Lavie F; Janssen-Cilag, Medical Affairs, Issy-les-Moulineaux, France.
  • Daperno M; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Lukás M; Clinical Center ISCARE, Clinical and Research Center for Inflammatory Bowel Diseases, Prague, Czech Republic.
  • Armuzzi A; IBD Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Löwenberg M; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Gaya DR; Glasgow Royal Infirmary, Glasgow, UK.
  • Peyrin-Biroulet L; Department of Gastroenterology, Nancy University Hospital, Nancy, France; INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
Lancet Gastroenterol Hepatol ; 7(4): 294-306, 2022 04.
Article in En | MEDLINE | ID: mdl-35120656
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Ustekinumab Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2022 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Ustekinumab Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2022 Document type: Article Country of publication: Netherlands